Is there immunity to Schistosoma japonicum?

Parasitology Today

Volumn 16, Issue 4, 2000, Pages 159-164

  Ross, Allen G P ^a   Sleigh, Adrian C ^a   Li, Yuesheng S ^a   Williams, Gail M ^a   Aligui, Gemiliano D L ^b   McManus, Don P ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E ANTIBODY; SCHISTOSOMA VACCINE; WATER;

ADOLESCENT; ADULT; AFRICA; AGE; ASIA; CELLULAR IMMUNITY; CHILD; CHINESE; FEMALE; HUMAN; IMMUNITY; INFECTION RESISTANCE; MALE; PHILIPPINES; PREVALENCE; REVIEW; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANIMALS; ANTIBODIES, HELMINTH; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; PREVALENCE; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SEX DISTRIBUTION;

JAPONICA; SCHISTOSOMA; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS JAPONICA; SCHISTOSOMIASIS MANSONI;

EID: 0034177412     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(99)01621-X     Document Type: Review

References (57)

1. Butterworth A.E.et al. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals and analysis of their immune responses. Trans. R. Soc. Trop. Med. Hyg. 79:1985;393-408.
2. Kabatereine N.B.et al. Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns. Parasitology. 118:1999;101-105.
3. Dessein A.J.et al. Human resistance to schistosomiasis is associated with IgG reactivity to a 37 kDa larval surface antigen. J. Immunol. 140:1988;2727-2736.
4. Wilkins H.A.et al. Resistance to reinfection after treatment of urinary schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 81:1987;29-35.
5. Wu Z.et al. Reinfection with Schistosoma japonicum after treatment with praziquantel in the Poyang Lake region, China. Southeast Asian J. Trop. Med. Public Health. 25:1994;163-169.
6. Zhang Z.et al. Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum. Trans. R. Soc. Trop. Med. Hyg. 91:1997;606-608.
7. Olveda R.M.et al. Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity. J. Infect. Dis. 174:1996;163-172.
8. Gryseels B. Uncertainties in the epidemiology and control of schistosomiasis. Am. J. Trop. Med. Hyg. 55:1996;103-108.
9. Ross A.G.P.et al. Epidemiologic identification of Chinese individuals putatively susceptible or unsusceptible to Schistosoma japonicum: a prelude to immunogenetic study of human resistance to Asian schistosomiasis. Ann. Trop. Med. Parasitol. 92:1998;765-774.
10. Ross A.G.P.et al. Activity diaries to assess human water contact patterns for schistosomiasis japonica in the Dongting Lake region of China I. A comparison with other exposure instruments. Acta Trop. 71:1998;213-228.
11. Ross A.G.P.et al. Activity diaries to assess human water contact patterns for schistosomiasis japonica in the Dongting Lake region of China II. Activity diaries and path analysis to predict infection. Acta Trop. 71:1998;229-236.
12. Dalton P.R., Pole D. Water-contact patterns in relation to Schistosoma haematobium infection. Bull. WHO. 56:1978;417-426.
13. Tayo M.A.et al. Malumfashi endemic diseases research project, XI. Water-contact activities in the schistosomiasis study area. Ann. Trop. Med. Parasitol. 74:1980;347-354.
14. Farooq M., Mallah M.B. The behavioural pattern of social and religious water-contact activities in the Egypt-49 bilharziasis project area. Bull. WHO. 35:1966;377-387.
15. Husting E.I. Human water contact activities related to the transmission of bilharziasis (schistosomiasis). J. Trop. Med. Hyg. 86:1983;23-35.
16. Fulford A.J.C.et al. Water-contact observations in Kenya communities endemic for schistosomiasis; methodology and patterns of behaviour. Parasitology. 113:1996;223-241.
17. Huang Y., Manderson L. Schistosomiasis and the social patterning of infection. Acta Trop. 51:1992;175-194.
18. Sleigh A.C., Mott K.E. Schistosomiasis. Gilles H.M. Epidemiology and Control of Tropical Diseases (Clinics in Tropical Medicine and Communicable Diseases 1). 1986;643-670 WB Saunders.
19. Etard J.F.et al. Age-acquired resistance and predisposition to reinfection with Schistosoma haematobium after treatment with praziquantel in Mali. Am. J. Trop. Med. Hyg. 52:1995;549-558.
20. Office of Endemic Diseases Control (1989) Epidemiological Situation of Schistosomiasis in China-Results of a Nation-wide Sampling Survey in 1989, Ministry of Public Health, People's Republic of China, Beijing.
21. Office of Endemic Diseases Control (1997) Epidemiological Situation of Schistosomiasis in China-Results of a Nation-wide Sampling Survey in 1995, Ministry of Public Health, People's Republic of China, Beijing.
22. Hunan Institute of Parasitic Diseases Reports (1995) Results of Sampling Surveys from Four Villages in West Dongting Lake, Hunan Province, 1991-1995, Hunan Institute of Parasitic Diseases, People's Republic of China, Yueyang (in Chinese).
23. Ross A.G.P.et al. Epidemiologic features of Schistosoma japonicum among fishermen and other occupational groups in the Dongting Lake region (Hunan Province) of China. Am. J. Trop. Med. Hyg. 57:1997;302-308.
24. Wiest P.et al. Impact of annual screening and chemotherapy with praziquantel on schistosomiasis japonica on Jishan Island, People's Republic of China. Am. J. Trop. Med. Hyg. 51:1994;162-169.
25. Olveda R.M.et al. Relationship of prevalence and intensity of infection to morbidity in schistosomiasis japonica: a study of three communities in Leyte, Philippines. Am. J. Trop. Med. Hyg. 32:1983;1312-1321.
26. Li Y.S.et al. A 2-year prospective study in China provides epidemiological evidence for resistance in humans to re-infection with Schistosoma japonicum. Ann. Trop. Med. Parasitol. 93:1999;629-642.
27. Fulford A.J.C.et al. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol. Today. 14:1998;23-26.
28. Demeure C.E.et al. Resistance to Schistosoma mansoni in humans. influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy J. Infect. Dis. 168:1993;1000-1008.
29. Hagan P.et al. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature. 349:1991;243-245.
30. Rihet P.et al. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area. Eur. J. Immunol. 22:1992;2063-2070.
31. Li Y.S. et al. Antibody isotype responses, infection and re-infection for Schistosoma japonicum in a marshland area of China. Acta Trop. 73:1999;79-92.
32. Webster M.et al. The influence of sex and age on antibody isotype responses to Schistosoma mansoni and Schistosoma japonicum in human populations in Kenya and the Philippines. Parasitology. 114:1997;383-393.
33. Waine G.J., McManus D.P. Schistosomiasis vaccine development-the current picture. BioEssays. 19:1997;435-443.
34. Webster M.et al. Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment. Infect. Immun. 64:1996;4042-4062.
35. Santiago M.L.et al. Identification of the Schistosoma japonicum 22.6-kDa antigen as a major target of the human IgE response: similarity of IgE binding epitopes to allergen peptides. Int. Arch. Allergy Immunol. 117:1998;94-104.
36. Hafalla J.C.R.et al. Molecular identification of a 21.7 kDa Schistosoma japonicum antigen as a target of the human IgE response. Mol. Biochem. Parasitol. 98:1999;157-161.
37. Waine G.J.et al. Production of IgE antibodies against the 22-kDa tegumental membrane-associated antigen of schistosomes is directed by the antigen itself. Parasite Immunol. 19:1997;531-533.
38. Roberts M.et al. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect. Immun. 61:1993;4984-4993.
39. Vianna I.R.C.et al. Interferon-γ production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg. 88:1994;466-470.
40. Grogan J.L.et al. Antigen-specific proliferation and interferon-γ and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J. Infect. Dis. 177:1998;1433-1437.
41. Medhat A.et al. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J. Infect. Dis. 178:1998;512-519.
42. Waine G.J.et al. Differential antigen stimulated proliferation of human mononuclear cells by recombinant Schistosoma japonicum antigens in a Chinese population. Clin. Exp. Immunol. 112:1998;69-73.
43. Kohlstadt S.et al. Characterisation of a schistosome T-cell stimulating antigen (Sm10) associated with protective immunity in humans. Mol. Biochem. Parasitol. 84:1997;155-165.
44. McManus D.P.et al. Production of interleukin-10 by peripheral blood mononuclear cells from residents of a marshland area in China endemic for Schistosoma japonicum. Parasitol. Int. 48:1999;169-177.
45. Abel L.et al. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am. J. Hum. Genet. 48:1991;959-970.
46. Marquet S.et al. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14:1996;181-184.
47. Muller-Myhsok B.et al. Further evidence suggesting the presence of a locus on human chromosome 5q31-q33 influencing the intensity of infection with Schistosoma mansoni. Am. J. Hum. Genet. 61:1997;452-454.
48. Marquet S. Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Eur. J. Hum. Genet. 7:1999;88-97.
49. Rodrigues V. Jr et al. Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes. Infect. Immun. 67:1999;4689-4692.
50. Waine G.J.et al. HLA class II antigens are associated with resistance or susceptibility to hepatic disease in a Chinese population infected with Schistosoma japonicum. Int. J. Parasitol. 28:1998;537-542.
51. Hirayama K.et al. Glycine-valine dimorphism at the 86th amino acid of HLA-DRB1 influenced the prognosis of postschistosomal hepatic fibrosis. J. Infect. Dis. 177:1998;1682-1686.
52. Hirayama K.et al. HLA-DR-DQ alleles and HLA-DP alleles are independently associated with susceptibility to different stages of post-schistosomal hepatic fibrosis in the Chinese population. Tissue Antigens. 53:1999;269-274.
53. Dessein A.J.et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am. J. Hum. Genet. 65:1999;709-721.
54. Ross A.G.P.et al. Schistosomiasis control in the People's Republic of China. Parasitol. Today. 13:1997;152-155.
55. Chen M.G., Feng Z. Schistosomiasis control in China. Parasitol. Int. 48:1999;11-19.
56. Sleigh A.et al. Eradication of schistosomiasis in Guangxi, China. Part 3: community diagnosis of the worst affected areas and maintenance strategies for the future. Bull. WHO. 76:1998;581-590.
57. Guyatt H.L., Tanner M. Different approaches to modeling the cost-effectiveness of schistosomiasis control. Am. J. Trop. Med. Hyg. 55:1996;159-164.